Clinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
NCT01890265 is registered in ClinicalTrials.gov with Kyntra Bio as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
- Lead sponsor
- Kyntra Bio
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 30, 2013
- Completion date
- November 16, 2017
- Enrollment
- 160 (actual)
- Sites
- 42
Conditions
As the registry lists them; a condition with its own page is linked.